LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02105 LAEKNA-B

Market Closed 06-26 16:08:11

6.220

-0.390

-5.90%

High6.610	Low6.140	Vol1.58M
Open6.610	D1 Closing6.610	Amplitude7.11%
Mkt Cap2.79B	Tradable Cap2.79B	Total Shares449.00M
T/O9.86M	T/O Rate0.35%	Tradable Shares449.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02105","market":"HK","secType":"STK","nameCN":"LAEKNA-B","latestPrice":6.22,"timestamp":1782461291004,"preClose":6.61,"halted":0,"volume":1579000,"delay":0,"changeRate":-0.05900151285930417,"floatShares":449000000,"shares":449000000,"eps":-0.59,"marketStatus":"Market Closed","change":-0.39,"latestTime":"06-26 16:08:11","open":6.61,"high":6.61,"low":6.14,"amount":9861992,"amplitude":0.071104,"askPrice":6.22,"askSize":500,"bidPrice":6.16,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.565,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782696600000},"marketStatusCode":7,"adr":0,"listingDate":1687968000000,"exchange":"SEHK","adjPreClose":6.61,"openAndCloseTimeList":[[1782437400000,1782446400000],[1782450000000,1782460800000]],"volumeRatio":0.469041,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02105/tweets","defaultTab":"tweets","newsList":[{"id":"1188055980","title":"LAEKNA-B Shares Surge Over 5% Following Global Licensing Deal for LAE118 with Vasque Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1188055980","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188055980?lang=en_us&edition=fundamental","pubTime":"2026-06-12 11:51","pubTimestamp":1781236298,"startTime":"0","endTime":"0","summary":"Shares of LAEKNA-B (02105) rose more than 5% in morning trading. At the time of writing, the stock was up 4.78% to HK$9.42, with a turnover of approximately HK$14.23 million.The upward movement...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","VXUS","02105","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128490287","title":"LAEKNA-B Secures Landmark Up to $527 Million Deal for PI3Kα Inhibitor LAE118, Pioneering NewCo 2.0 Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1128490287","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128490287?lang=en_us&edition=fundamental","pubTime":"2026-06-11 08:43","pubTimestamp":1781138600,"startTime":"0","endTime":"0","summary":"A business development deal is not unusual, but securing up to 50% of the profit share makes it a potential blockbuster transaction.On the morning of June 10th, LAEKNA-B (ASX: 02105) announced a...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UGL","SGCmain","BGLD","BK4585","159831","JDST","XME","DGP","GOAU","BK1161","GLDM","GDX","GDXD","GLDY","GOLY","IAUI","IAUM","IGLD","BAR","BK4504","BEGS","518880","DZZ","RING","DULL","NUGT","GLTR","SGDM","159934","GLL","PALL","BTGD","IAU","CEF","FGDL","GCmain","QOmain","KGLD","YGLD","PICK","JNUG","USG","GLD","1OZmain","02105","DUST","SGOL","SHNY","GBUG","DBC","DGZ","GDXY","BK4535","SGUmain","UYM","AAAU","OUNZ","BK4207","MGCmain","BK4588","PHYS","GDXJ","GDXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642449257","title":"Hong Kong Stocks Fall as U.S.-Iran Hostilities Escalate; WuXi AppTec Gains on Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2642449257","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642449257?lang=en_us&edition=fundamental","pubTime":"2026-06-10 16:40","pubTimestamp":1781080850,"startTime":"0","endTime":"0","summary":"Hong Kong stocks declined on Wednesday as Iran and the United States engaged in their biggest exchange of hostilities since a ceasefire was agreed in April.The Hang Seng Index fell 0.6%, or 157.94 poi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0348767384.USD","LU2242644610.SGD","LU1046422090.SGD","MCHmain","02833","BK1576","02359","03037","LU0708995583.HKD","83115","07200","HHImain","LU2045819591.USD","02800","BK1583","513600","82800","03419","LU0320764599.SGD","LU0052750758.USD","MHImain","BK1141","LU2125910500.SGD","02105","07500","BK1161","HSI","07300","603259","HSTECH","LU0348766576.USD","09115","03115"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642414263","title":"Laekna Licenses Cancer Drug Candidate to Vasque Bio Outside Greater China","url":"https://stock-news.laohu8.com/highlight/detail?id=2642414263","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642414263?lang=en_us&edition=fundamental","pubTime":"2026-06-10 11:29","pubTimestamp":1781062147,"startTime":"0","endTime":"0","summary":"Laekna  granted Vasque Bio exclusive rights to develop and commercialize its cancer drug candidate LAE118 outside Greater China under a licensing agreement, according to a Wednesday Hong Kong bourse filing.The biotechnology company will receive a $10 million upfront payment and is eligible for up to $517 million in development and sales milestone payments under the deal.Laekna will also have the right to acquire, at no additional cost, up to a high-teen-percentage stake in Vasque Bio's outstanding common stock, or to receive cash payments in lieu of the shares.In addition, the company is entitled to tiered royalties ranging from single-digit to double-digit percentages on future net sales of LAE118 in the licensed territory.It may also receive additional payments tied to certain strategic transactions involving the drug candidate, the filing said.Shares of Laekna were down over 4% in Wednesday morning trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135901688","title":"LAEKNA-B Inks Exclusive Licensing Pact for LAE118 Outside Greater China with VASQUE BIO","url":"https://stock-news.laohu8.com/highlight/detail?id=1135901688","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135901688?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:20","pubTimestamp":1781050852,"startTime":"0","endTime":"0","summary":"LAEKNA-B has entered into a new licensing arrangement concerning its proprietary drug candidate.On June 9, 2026, the company executed an exclusive licensing agreement with VASQUE BIO, Inc. Under the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIO","BK4121","BK1161","BK4588","LU1169589451.USD","LU1169590202.USD","02105","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642641555","title":"Laekna - to Receive $10 Mln Upfront Cash Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2642641555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642641555?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:10","pubTimestamp":1781050247,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42H0QS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642415553","title":"Laekna - Vasque Bio Granted Exclusive Worldwide License (Ex-China) for Lae118","url":"https://stock-news.laohu8.com/highlight/detail?id=2642415553","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642415553?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:10","pubTimestamp":1781050247,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42H0QS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642155584","title":"Laekna - Enters Exclusive License Agreement With Vasque Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2642155584","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642155584?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:10","pubTimestamp":1781050247,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42H0QS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02105","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642041555","title":"Laekna - Eligible for up to $517 Mln in Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2642041555","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642041555?lang=en_us&edition=fundamental","pubTime":"2026-06-10 08:10","pubTimestamp":1781050247,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nFWN42H0QS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111046279","title":"Laekna AGM: Shareholders Unanimously Pass All Resolutions, Green-Light 2.55 Million RSU Grants to Key Executives","url":"https://stock-news.laohu8.com/highlight/detail?id=1111046279","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111046279?lang=en_us&edition=fundamental","pubTime":"2026-06-05 18:03","pubTimestamp":1780653793,"startTime":"0","endTime":"0","summary":"Laekna, Inc. held its Annual General Meeting on 5 June 2026, with every agenda item securing shareholder approval by poll. The audited consolidated financial statements for the year ended 31 December...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120381194","title":"Laekna Issues 2.87 Million New Shares Under 2024 Share Award Scheme; Total Outstanding Reaches 449.33 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120381194","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120381194?lang=en_us&edition=fundamental","pubTime":"2026-06-04 17:25","pubTimestamp":1780565122,"startTime":"0","endTime":"0","summary":"Laekna, Inc. (Laekna) reported a month-end issued share count of 449.33 million ordinary shares as of 31 May 2026, up by 2.87 million shares from April. The entire increase stemmed from new shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144605010","title":"Laekna Announces 5 June 2026 AGM; Share Issuance and Buy-back Mandates, Director Re-elections and 7.65 Million RSU Grants on Agenda","url":"https://stock-news.laohu8.com/highlight/detail?id=1144605010","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144605010?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:05","pubTimestamp":1778771144,"startTime":"0","endTime":"0","summary":"Laekna, Inc. (LAEKNA-B) has issued a notice convening its Annual General Meeting (AGM) for 9:00 a.m. on 5 June 2026 at the company’s Shanghai headquarters (5F, 987 Cailun Road, Pudong). Key...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127445217","title":"Laekna Outlines 2026 AGM Agenda: New Share Mandates, Director RSU Grants and Auditor Re-appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1127445217","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127445217?lang=en_us&edition=fundamental","pubTime":"2026-05-14 23:05","pubTimestamp":1778771118,"startTime":"0","endTime":"0","summary":"Laekna, Inc. has released its 2026 AGM circular detailing a series of resolutions that shareholders will vote on 5 June 2026 in Shanghai. Key proposals 1. Capital mandates   • Issue & Resell Mandate:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635746573","title":"Laekna schedules annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2635746573","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635746573?lang=en_us&edition=fundamental","pubTime":"2026-05-14 22:47","pubTimestamp":1778770076,"startTime":"0","endTime":"0","summary":"Laekna annual general meeting set for June 5, 2026 in Shanghai.Shareholders will vote on mandates to issue shares, resell treasury shares, repurchase shares, plus an extension mandate tied to any repurchases.Meeting also seeks re-election of directors, re-appointment of KPMG as auditor for year ending Dec. 31, 2025.Separate resolutions cover grants of 2,550,000 RSUs each to Chris Xiangyang Lu, Ling Xie, Xiang-Ju Justin Gu under 2024 Share Award Scheme, with 25% vesting on each anniversary over four years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laekna Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 14, 2026, and is sol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDLc0DlqW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173492016","title":"LAEKNA-B Shares Surge Over 5% in Morning Session as LAE002 Phase III Trial Hits Primary Endpoint, NDA Submission Imminent","url":"https://stock-news.laohu8.com/highlight/detail?id=1173492016","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173492016?lang=en_us&edition=fundamental","pubTime":"2026-05-14 12:04","pubTimestamp":1778731498,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) rose more than 5% in morning trading. As of the time of writing, the stock was up 5.14% to HK$14.32, with a turnover of HK$13.01 million. The catalyst for the move is the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4588","IPOS","VXUS","BK4585","BK4134","02105","III"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150537771","title":"MSCI's May Global Small-Cap Index Rebalancing: 14 Additions Including Meitu and 21 Deletions Such as CIG","url":"https://stock-news.laohu8.com/highlight/detail?id=1150537771","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150537771?lang=en_us&edition=fundamental","pubTime":"2026-05-13 10:27","pubTimestamp":1778639221,"startTime":"0","endTime":"0","summary":"On May 13, the global index provider MSCI Inc. announced the results of its quarterly index review for May 2026, with the changes set to take effect after market close on May 29. For the MSCI Global...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2125910849.SGD","603083","BK4550","BK1128","RWM","LU1691799644.USD","LU0289739343.SGD","UWM","LU0082770016.USD","RSSL","00357","000898","BK1615","00347","IWMI","BK4588","LU0320765059.SGD","09985","BK4534","MNQmain","VTWO","LU0289960550.SGD","TWM","BK4585","BK4535","LU0109391861.USD","LU1804176565.USD","01515","BK1095","VB","LU0289961442.SGD","LU2210150020.SGD","LU0620787316.HKD","00315","00772","BK1149","LU0082770016.SGD","02105","002936","SRTY","BK4112","06196","BK1609","LU2210149790.SGD","01357","MGRT","BK1618","06166","BK4581","01523","LU0231459107.USD","LU0278937759.USD","RYLD","LU2095319765.USD","BK1612","LU0672654240.SGD","LU2125910500.SGD","IWN","LU2265009873.SGD","AVUV","BK1240","LU0164939612.USD","BK0214","IE00BKPKM429.USD","00327","02373","LU0511384066.AUD","LU0708995401.HKD","09899","IWF","LU1267930730.SGD","LU2045819591.USD","BK1613","IE0009570106.USD","MSCI","LU0175139822.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179222950","title":"Stock Track | LAEKNA-B Plummets 8.59% Intraday Amid Insider Selling Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1179222950","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179222950?lang=en_us&edition=fundamental","pubTime":"2026-05-12 13:40","pubTimestamp":1778564440,"startTime":"0","endTime":"0","summary":"LAEKNA-B stock experienced a significant decline, plummeting 8.59% during intraday trading on Tuesday.The sharp drop appears to be linked to investor reaction following news of insider selling...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02105"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634125263","title":"Laekna Sees Insider Stock Selling","url":"https://stock-news.laohu8.com/highlight/detail?id=2634125263","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634125263?lang=en_us&edition=fundamental","pubTime":"2026-05-12 10:40","pubTimestamp":1778553610,"startTime":"0","endTime":"0","summary":"Looking at Laekna, Inc.'s ( HKG:2105 ) insider transactions over the last year, we can see that insiders were net...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2105/laekna-shares/news/laekna-sees-insider-stock-selling","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2105/laekna-shares/news/laekna-sees-insider-stock-selling","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02105","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122306758","title":"LAEKNA-B Shares Surge Over 10% in Afternoon Trading as Qilu Pharmaceutical Advances LAE002 NDA; Company Poised for Upfront and Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=1122306758","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122306758?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:48","pubTimestamp":1778482108,"startTime":"0","endTime":"0","summary":"LAEKNA-B shares surged over 10% in afternoon trading. As of the latest update, the stock was up 9.63%, trading at HKD 14.8 with a turnover of HKD 60.8913 million. On April 15, the company formally...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK1574","IPOS","02105","BK1191","BK4588","BK1161","BK4585","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634750364","title":"Laekna Grants Restricted Share Units to Directors, Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2634750364","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634750364?lang=en_us&edition=fundamental","pubTime":"2026-05-11 11:12","pubTimestamp":1778469175,"startTime":"0","endTime":"0","summary":"Laekna  said it granted 15.3 million restricted share units to three executive directors and employees, according to a Friday filing with the Hong Kong bourse.The drug company's shares gained nearly 5% in morning trade Monday.Of the total, 7.7 million RSUs were earmarked for employees, while an additional 2.6 million RSUs were granted to Lu Chris Xiangyang, Gu Xiang-Ju Justin, and Xie Ling.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02105","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.laekna.com","stockEarnings":[{"period":"1week","weight":-0.1772},{"period":"1month","weight":-0.4988},{"period":"3month","weight":-0.5945},{"period":"6month","weight":-0.5557},{"period":"1year","weight":-0.645},{"period":"ytd","weight":-0.5416}],"compareEarnings":[{"period":"1week","weight":-0.0524},{"period":"1month","weight":-0.1049},{"period":"3month","weight":-0.0914},{"period":"6month","weight":-0.1219},{"period":"1year","weight":-0.068},{"period":"ytd","weight":-0.1154}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer, liver diseases and obesity. The Company is still in the research and development stage. The Company's pipeline products include Afuresertib (LAE002), LAE001, LAE109, LAE111, LAE112, LAE113, LAE117, LAE118, LAE119, LAE102, LAE103, LAE104, LAE105, LAE106, LAE120, LAE123, and others. The Afuresertib is an adenosine triphosphate (ATP) competitive AKT inhibitor. The LAE001 is an androgen synthesis inhibitor that can inhibit CYP17A1 and CYP11B2 at the same time. The Company mainly conducts business in the Chinese, America, European, Korean, and other markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.264392},{"month":2,"riseRate":0.666667,"avgChangeRate":0.234103},{"month":3,"riseRate":0.666667,"avgChangeRate":0.090739},{"month":4,"riseRate":0.333333,"avgChangeRate":0.001974},{"month":5,"riseRate":0.666667,"avgChangeRate":0.062052},{"month":6,"riseRate":0,"avgChangeRate":-0.240778},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.063454},{"month":8,"riseRate":0.666667,"avgChangeRate":0.069227},{"month":9,"riseRate":0.666667,"avgChangeRate":0.04052},{"month":10,"riseRate":0.666667,"avgChangeRate":0.10793},{"month":11,"riseRate":1,"avgChangeRate":0.401946},{"month":12,"riseRate":0,"avgChangeRate":-0.176326}],"exchange":"SEHK","name":"LAEKNA-B","nameEN":"LAEKNA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest LAEKNA-B(02105) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"LAEKNA-B,02105,LAEKNA-B股票,LAEKNA-B股票老虎,LAEKNA-B股票老虎国际,LAEKNA-B行情,LAEKNA-B股票行情,LAEKNA-B股价,LAEKNA-B股市,LAEKNA-B股票价格,LAEKNA-B股票交易,LAEKNA-B股票购买,LAEKNA-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"LAEKNA-B(02105),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest LAEKNA-B(02105) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}